Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bubendorf

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Nature Medicine|July 14, 1998
Tissue microarrays for high-throughput molecular profiling of tumor specimensJ Kononen, L Bubendorf, A Kallioniemi, et al.
The American Journal of Pathology|September 1, 1997
Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancerU Wagner, L Bubendorf, T C Gasser, et al.
Cancer Research|February 24, 1999
Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarraysL Bubendorf, J Kononen, P Koivisto, et al.
British Journal of Cancer|December 19, 2007
Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancersS Savic, C Tapia, B Grilli, et al.
Pneumologie (Stuttgart, Germany)|April 12, 2013
[Diagnostic and predictive analyses of cytological specimens of non-small cell lung cancer: strategies and challenges]F J F Herth, L Bubendorf, S Gütz, et al.
Journal of Clinical Pathology|April 30, 2003
Guidelines for processing and reporting of prostatic needle biopsiesTh H van der Kwast, C Lopes, C Santonja, et al.
Oncogene|December 26, 2001
Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signalingS Mousses, U Wagner, Y Chen, et al.
British Journal of Cancer|May 24, 2014
Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancerN Cihoric, S Savic, S Schneider, et al.
Disease Markers|October 24, 2001
ANX7 as a bio-marker in prostate and breast cancer progressionM Srivastava, L Bubendorf, L Nolan, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2010
Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate CancerM Laurila, T van der Kwast, L Bubendorf, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Nature Medicine|July 14, 1998
Tissue microarrays for high-throughput molecular profiling of tumor specimensJ Kononen, L Bubendorf, A Kallioniemi, et al.
The American Journal of Pathology|September 1, 1997
Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancerU Wagner, L Bubendorf, T C Gasser, et al.
Cancer Research|February 24, 1999
Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarraysL Bubendorf, J Kononen, P Koivisto, et al.
British Journal of Cancer|December 19, 2007
Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancersS Savic, C Tapia, B Grilli, et al.
Pneumologie (Stuttgart, Germany)|April 12, 2013
[Diagnostic and predictive analyses of cytological specimens of non-small cell lung cancer: strategies and challenges]F J F Herth, L Bubendorf, S Gütz, et al.
Journal of Clinical Pathology|April 30, 2003
Guidelines for processing and reporting of prostatic needle biopsiesTh H van der Kwast, C Lopes, C Santonja, et al.
Oncogene|December 26, 2001
Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signalingS Mousses, U Wagner, Y Chen, et al.
British Journal of Cancer|May 24, 2014
Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancerN Cihoric, S Savic, S Schneider, et al.
Disease Markers|October 24, 2001
ANX7 as a bio-marker in prostate and breast cancer progressionM Srivastava, L Bubendorf, L Nolan, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2010
Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate CancerM Laurila, T van der Kwast, L Bubendorf, et al.
Pageof 9